Smith Robin L

Other

US·SEC (Form 4)

Sorrento Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the full record of transactions filed by Smith Robin L. Director active across 1 companies, notably Sorrento Therapeutics, Inc.. In total, 2 disclosures have been published. The latest transaction was filed on 3 September 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.

Declarations2 total

Executives◇OptionsSSorrento Therapeutics, Inc.17SEC

S

Smith Robin LDirector

€249,44375,000 shares@ €3.3259100.0% of flow

Common Stock

SEC:0001209191-21-054841·3 Sept 2021

SEC ↗

Executives◇OptionsSSorrento Therapeutics, Inc.21SEC

S

Smith Robin LDirector

€249,44375,000 shares@ €3.32590.060% mcap50.0% of flow